Correlation Between Talaris Therapeutics and Edgewise Therapeutics
Can any of the company-specific risk be diversified away by investing in both Talaris Therapeutics and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Talaris Therapeutics and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Talaris Therapeutics and Edgewise Therapeutics, you can compare the effects of market volatilities on Talaris Therapeutics and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Talaris Therapeutics with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Talaris Therapeutics and Edgewise Therapeutics.
Diversification Opportunities for Talaris Therapeutics and Edgewise Therapeutics
0.27 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Talaris and Edgewise is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Talaris Therapeutics and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and Talaris Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Talaris Therapeutics are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of Talaris Therapeutics i.e., Talaris Therapeutics and Edgewise Therapeutics go up and down completely randomly.
Pair Corralation between Talaris Therapeutics and Edgewise Therapeutics
Given the investment horizon of 90 days Talaris Therapeutics is expected to generate 0.98 times more return on investment than Edgewise Therapeutics. However, Talaris Therapeutics is 1.02 times less risky than Edgewise Therapeutics. It trades about 0.12 of its potential returns per unit of risk. Edgewise Therapeutics is currently generating about 0.07 per unit of risk. If you would invest 142.00 in Talaris Therapeutics on August 24, 2024 and sell it today you would earn a total of 156.00 from holding Talaris Therapeutics or generate 109.86% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 32.06% |
| Values | Daily Returns |
Talaris Therapeutics vs. Edgewise Therapeutics
Performance |
| Timeline |
| Talaris Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Edgewise Therapeutics |
Talaris Therapeutics and Edgewise Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Talaris Therapeutics and Edgewise Therapeutics
The main advantage of trading using opposite Talaris Therapeutics and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Talaris Therapeutics position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.| Talaris Therapeutics vs. Edgewise Therapeutics | Talaris Therapeutics vs. Adicet Bio | Talaris Therapeutics vs. Cullinan Oncology LLC | Talaris Therapeutics vs. Vor Biopharma |
| Edgewise Therapeutics vs. Lyra Therapeutics | Edgewise Therapeutics vs. Hookipa Pharma | Edgewise Therapeutics vs. Cingulate Warrants | Edgewise Therapeutics vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |